ANABEL VENEREO CANTILLO: Open Payments
NPI 1518534486 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 16 payments from 9 companies in 2025. Trend: 2023 $341 · 2024 $484 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $166 |
| Regeneron Healthcare Solutions, Inc. | 1 | $114 |
| Janssen Biotech, Inc. | 2 | $57 |
| PFIZER INC. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| JAZZ PHARMACEUTICALS INC. | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
Products named: Enhertu, LIBTAYO, JEMPERLI, KEYTRUDA, DARZALEX, DATROWAY, ELREXFIO, BOSULIF.
Industry payments across FL — which companies pay providers there.
